Prescribing guidance
Prescribing guidance and pathways for healthcare professionals across NHS Central East ICB.
-
Chronic Kidney Disease
Chronic kidney disease (CKD) is a long-term condition in which kidney function gradually declines over time. This page provides information to support the identification, management and monitoring of CKD in line with best clinical practice.
-
Cinacalcet
Cinacalcet is used in the management of hyperparathyroidism and disorders of calcium and phosphate balance. This page provides information to support the safe prescribing, monitoring and ongoing management of cinacalcet therapy.
-
Disease modifying anti-rheumatic drugs (DMARDs)
Disease modifying anti-rheumatic drugs (DMARDs) are used to treat a range of inflammatory and autoimmune conditions by reducing disease activity and preventing long-term complications. This page provides information on the safe use, monitoring and management of DMARD therapy.
-
Finerenone
Finerenone is a medicine used in people with chronic kidney disease associated with type 2 diabetes to help reduce the risk of kidney disease progression and cardiovascular complications. This page provides information to support the safe prescribing, monitoring and ongoing management of finerenone therapy.
-
Lanthanum
Lanthanum is a medicine used to help lower phosphate levels in people with chronic kidney disease. This page provides information on the use and management of lanthanum as part of the treatment of phosphate imbalance associated with kidney disease.
-
Patiromer calcium
Patiromer calcium is a medicine used to treat high potassium levels in people with chronic kidney disease, heart failure and certain other conditions. This page provides information on the safe use and monitoring of patiromer treatment.
-
Sevelamer carbonate
Sevelamer carbonate is a medicine used to help lower phosphate levels in people with chronic kidney disease. This page provides information on the use and management of sevelamer carbonate as part of the treatment of phosphate imbalance associated with kidney disease.
-
Sodium zirconium cyclosilicate
Sodium zirconium cyclosilicate is a medicine used to treat high potassium levels in people with chronic kidney disease, heart failure and certain other conditions. This page provides information on the safe use and monitoring of sodium zirconium cyclosilicate treatment
-
Sucroferric oxyhydroxide
Sucroferric oxyhydroxide is a medicine used to help lower phosphate levels in people with advanced chronic kidney disease who require dialysis. This page provides information on the use and management of sucroferric oxyhydroxide as part of the treatment of phosphate imbalance associated with kidney disease.
-
Tolvaptan
Tolvaptan is a medicine used to help slow the progression of autosomal dominant polycystic kidney disease (ADPKD), an inherited condition that causes fluid-filled cysts to develop in the kidneys. This page provides information on the safe use, monitoring and ongoing management of tolvaptan treatment.